Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Magnusson, Nils E ^a,b   Hornum, Mads ^c   Jørgensen, Kaj Anker ^b   Hansen, Jesper Melchior ^d   Bistrup, Claus ^e   Feldt Rasmussen, Bo ^c   Flyvbjerg, Allan ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

^d Mental Health Center Glostrup   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HOMOCYSTEINE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE DURATION; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOASSAY; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; UREMIA; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; KIDNEY FUNCTION TEST; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; TIME;

ACUTE-PHASE PROTEINS; ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIPOCALINS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; TIME FACTORS; UREMIA;

EID: 84856792915     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-8     Document Type: Article

References (46)

1. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N: Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993, 268(14):10425-10432. (Pubitemid 23150227)
2. Patel RC, Lange D, McConathy WJ, Patel YC, Patel SC: Probing the structure of the ligand binding cavity of lipocalins by fluorescence spectroscopy. Protein Eng 1997, 10(6):621-625. (Pubitemid 27332068)
3. Hvidberg V, Jacobsen C, Strong RK, Cowland JB, Moestrup SK, Borregaard N: The endocytic receptor megalin binds the iron transporting neutrophil- gelatinase- associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett 2005, 579(3):773-777.
4. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK: The Neutrophil Lipocalin NGAL Is a Bacteriostatic Agent that Interferes with Siderophore-Mediated Iron Acquisition. Mol Cell 2002, 10(5):1033, 1043..
5. Yang J, Mori K, Li JY, Barasch J: Iron, lipocalin, and kidney epithelia. Am J Physiol Renal Physiol 2003, 285(1):F9-18.
6. Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, Wakeham A, Fong HE, Cheung CC, Mak TW: Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci USA 2006, 103(6):1834-1839. (Pubitemid 43228779)
7. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A: Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004, 432(7019):917-921. (Pubitemid 40037155)
8. Xu SY, Pauksen K, Venge P: Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest 1995, 55(2):125-131.
9. Axelsson L, Bergenfeldt M, Ohlsson K: Studies of the release and turnover of a human neutrophil lipocalin. Scand J Clin Lab Invest 1995, 55(7):577-588.
10. Seveus L, Amin K, Peterson CG, Roomans GM, Venge P: Human neutrophil lipocalin (HNL) is a specific granule constituent of the neutrophil granulocyte. Studies in bronchial and lung parenchymal tissue and peripheral blood cells. Histochem Cell Biol 1997, 107(5):423-432. (Pubitemid 27226840)
11. Sunil VR, Patel KJ, Nilsen-Hamilton M, Heck DE, Laskin JD, Laskin DL: Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver. Exp Mol Pathol 2007, 83(2):177-187. (Pubitemid 47320654)
12. Liu M, Prisco M, Drakas R, Searles D, Baserga R: 24p3 in Differentiation of Myeloid Cells. J Cell Physiol 2005, 205(2):302-309. (Pubitemid 41428914)
13. Garay-Rojas E, Harper M, Hraba-Renevey S, Kress M: An apparent autocrine mechanism amplifies the dexamethasone- and retinoic acid-induced expression of mouse lipocalin-encoding gene 24p3. Gene 1996, 170(2):173-180. (Pubitemid 26140626)
14. Sorensen OE, Cowland JB, Theilgaard-Monch K, Liu L, Ganz T, Borregaard N: Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 2003, 170(11):5583-5589. (Pubitemid 36617848)
15. Jayaraman A, Roberts KA, Yoon J, Yarmush DM, Duan X, Lee K, Yarmush ML: Identification of neutrophil gelatinase-associated lipocalin (NGAL) as a discriminatory marker of the hepatocyte-secreted protein response to IL-1beta: a proteomic analysis. Biotechnol Bioeng 2005, 91(4):502-515. (Pubitemid 41099036)
16. Cowland JB, Sorensen OE, Sehested M, Borregaard N: Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol 2003, 171(12):6630-6639. (Pubitemid 37532095)
17. Pawluczyk IZ, Furness PN, Harris KP: Macrophage-induced rat mesangial cell expression of the 24p3-like protein alpha-2-microglobulin-related protein. Biochim Biophys Acta 2003, 1645(2):218-227. (Pubitemid 38229281)
18. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D'Agati V, Devarajan P, Barasch J: Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005, 115(3):610-621. (Pubitemid 40322235)
19. Bu DX, Hemdahl AL, Gabrielsen A, Fuxe J, Zhu C, Eriksson P, Yan ZQ: Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB. Am J Pathol 2006, 169(6):2245-2253. (Pubitemid 351181982)
20. Draper DW, Bethea HN, He YW: Toll-like receptor 2-dependent and -independent activation of macrophages by group B streptococci. Immunol Lett 2006, 102(2):202-214. (Pubitemid 43053089)
21. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003, 14(10):2534-2543. (Pubitemid 37169339)
22. Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P: Differential gene expression following early renal ischemia/reperfusion. Kidney Int 2003, 63(5):1714-1724. (Pubitemid 36513317)
23. Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV: Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 2004, 286(3):F552-63. (Pubitemid 38233650)
24. Malyszko J, Malyszko JS, Mysliwiec M: Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients. Clin Transplant 2009, 23(5):681-686.
25. Wagener G, Jan M, Kim M, Mori K, Barasch JM, Sladen RN, Lee HT: Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006, 105(3):485-491. (Pubitemid 44310430)
26. Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, Dragun D, Haase M: Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-a prospective cohort study. Crit Care Med 2009, 37(2):553-560.
27. Zappitelli M, Washburn KK, Arikan AA, Loftis L, Ma Q, Devarajan P, Parikh CR, Goldstein SL: Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care 2007, 11(4):R84.
28. Wheeler DS, Devarajan P, Ma Q, Harmon K, Monaco M, Cvijanovich N, Wong HR: Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 2008, 36(4):1297-1303. (Pubitemid 351482681)
29. Ling W, Zhaohui N, Ben H, Leyi G, Jianping L, Huili D, Jiaqi Q: Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract 2008, 108(3): c176-81. (Pubitemid 351588109)
30. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S: Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol 2006, 26(3):287-292. (Pubitemid 44121091)
31. Mishra J, Mori K, Ma Q, Kelly C, Yang J, Mitsnefes M, Barasch J, Devarajan P: Amelioration of ischemic acute renal injury by neutrophil gelatinaseassociated lipocalin. J Am Soc Nephrol 2004, 15(12):3073-3082. (Pubitemid 39578839)
32. Hornum M, Jorgensen KA, Hansen JM, Nielsen FT, Christensen KB, Mathiesen ER, Feldt-Rasmussen B: New-onset diabetes mellitus after kidney transplantation in Denmark. Clin J Am Soc Nephrol 2010, 5(4):709-716.
33. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34(Suppl 1):S62-9.
34. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22(9):1462, 1470.
35. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16(1):31-41.
36. Pedersen KR, Ravn HB, Hjortdal VE, Norregaard R, Povlsen JV: Neutrophil gelatinase-associated lipocalin (NGAL): validation of commercially available ELISA. Scand J Clin Lab Invest 2010, 70(5):374-382.
37. Malyszko J, Malyszko JS, Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S, Mysliwiec M: Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients. Transplant Proc 2009, 41(1):158-161.
38. Dewitte K, Fierens C, Stockl D, Thienpont LM: Application of the Bland- Altman Plot for Interpretation of Method-Comparison Studies: A Critical Investigation of Its Practice. Clin Chem 2002, 48(5):799-801. (Pubitemid 34439125)
39. [http://www.ncbi.nlm.nih.gov/pubmed?term= smertaUsingngalasanearlydiagnostictestofacutekidney2011].
40. de Vinuesa SG, Ortega M, Martinez P, Goicoechea M, Campdera FG, Luno J: Subclinical peripheral arterial disease in patients with chronic kidney disease: prevalence and related risk factors. Kidney Int Suppl 2005, 93(93): S44-7. (Pubitemid 40019215)
41. Parikh NI, Hwang SJ, Larson MG, Levy D, Fox CS: Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study). Am J Cardiol 2008, 102(1):47-53.
42. Giaginis C, Zira A, Katsargyris A, Klonaris C, Theocharis S: Clinical implication of plasma neutrophil gelatinase-associated lipocalin (NGAL) concentrations in patients with advanced carotid atherosclerosis. Clin Chem Lab Med 2010, 48(7):1035-1041.
43. Falke P, Elneihoum AM, Ohlsson K: Leukocyte activation: relation to cardiovascular mortality after cerebrovascular ischemia. Cerebrovasc Dis 2000, 10(2):97-101. (Pubitemid 30107503)
44. Forsblad J, Gottsater A, Persson K, Jacobsson L, Lindgarde F: Clinical manifestations of atherosclerosis in an elderly population are related to plasma neopterin, NGAL and endothelin-1, but not to Chlamydia pneumoniae serology. Int Angiol 2002, 21(2):173-179.
45. Castro R, Rivera I, Blom HJ, Jakobs C, Tavares de Almeida I: Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis 2006, 29(1):3-20.
46. Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Pawlak K, Dobrzycki S: Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease. Nephrology (Carlton) 2008, 13(2):153-156. (Pubitemid 351232835)